|
|
|
View this email in your browser
|
|
|
|
|
|
|
|
|
|
Dear
Wow, the year is nearly half over already. As its a busy time for everyone, I'll keep the intro short today.
Have you participated in a clinical trial? I'm currently looking for a few people from very different backgrounds and living circumstances to join a short term subcommittee for a project aiming to support researchers to make clinical trials more convenient for participants. If you'd like to know more about this, take a look here and watch the 4 min invitation video. I'll be wrapping up recruitment for this this week, so we can get started later in June, so don't delay if you're interested in helping trials to be delivered more flexibly.
|
|
|
So with that, I'll leave you to look at the studies recently listed on the ANZCTR as starting to look for participants. Have a great June, until our next 'Partnering' newsletter later in the month, and do say hello if you bump into me out and about, online, or in our Facebook Group.
|
|
|
|
The following is a list of studies on the ANZCTR as at 3 June starting between 1 May and 3 June 2025. For more details, click on the links to access the specific trial information.Cancer
- A Phase 1 Study of VIR-5525 Alone and in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors. NSW, QLD.
- Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases. VIC.
- A Phase 1/2 Clinical Trial to Assess ENV-501 in Patients With HER3-Expressing Solid Tumors. NSW.
- A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer. NSW, QLD.
- A Phase 2 Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion. NSW, QLD, SA.
- Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib. VIC.
- A Phase 1b Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone. NSW, VIC.
- A Phase IIIb, Open-label, Single-arm, Global Study of Perioperative Durvalumab With Neoadjuvant ddMVAC or Gem/Cis in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2), QLD, VIC, NSW, WA.
Diabetes - Comparison of Dietetics Support With and Without Continuous Glucose
Monitoring in Individuals With Type 2 Diabetes. VIC.
Kidney Disease - A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation. SA, QLD, VIC, NSW.
Respiratory Heart Related Eye Related Neurological - Effect of Swallowing Therapy on efficiency of eating and drinking in People with Parkinson’s Disease. NSW
- A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke. NSW, QLD, VIC.
Gastrointestinal - A Phase 2 Study to Assess Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Crohn's Disease. NSW, QLD.
Paediatric/Adolescent Healthy volunteers - Human Infection Study of H3N2 Influenza in Healthy Adults. VIC.
- Study to Evaluate Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults. QLD, VIC.
Other
|
|
|
Note we have no connection/involvement with any of the above studies. We source this list manually from ANZCTR. Unless otherwise indicated,
we have not being paid to list the study, and a study appearing in this list is not an endorsement of the quality, relevance of or consumer involvement in the project. We encourage people to do their due dligence on the suitability of any research study for their specific circumstances.
If you are a sponsor or researcher that wants to let people know about your newly opened study, please complete our request form or contact us (it's free to list a study once).
|
|
|
|
- Made With Patients Awards, Italy, 12 Jun 2am
If you are a night owl in Aus, you might like to dial into the PFMD Made With Patients Awards, being held in Italy as part of the Patient Engagement Open Forum. I'm excited to be named a finalist for the Champions Award, alongside 8 other amazing international advocates, with the winner being announced at this time. You can register for the livestream here.
|
|
|
|
Entries are now closed for these Awards. However, stay tuned later in June for your opportunity to vote for a people's choice award and register for the live virtual finals event. There is some truly exceptional work going on out there!
|
|
|
|
Do you have something to share in this newsletter? Submit a request to share it via the CCReW submission form.
|
|
|
|
Shop Now! Your purchase will help fund CCReW support activities like this newsletter, our 1800 Trials Helpline, CCReW travel scholarships, clinical trial participant thank you's & more. Visit the
shop.
|
|
|
|
|
|
|
|
You are receiving this email because you subscribed to this newsletter or the AccessCR database. Unsubscribe
|
|
|
|
|
|
|
AccessCR Pty Ltd
Ground floor
465 Victoria Avenue
Chatswood NSW 2067
Australia
|
|
|
|
|
|
|